Caris Caris Life Sciences Raises $400M in Senior Secured Debt Financing The company said it will use the proceeds to repay outstanding debt and enhance its precision medicine platform, in addition to funding general corporate activities. Caris Life Sciences Taps Juniper Biologics to Market Sequencing Tests in Southeast Asia The move will make Caris' comprehensive cancer sequencing services available to physicians and patients in the region. Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology. In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More News items for the week of Jan. 3, 2023. Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement The companies aim to use Caris' genomic and transcriptomic testing to identify biomarkers that can improve chances of success for the novel drug. Dec 2, 2022 In Brief This Week: BC Platforms, Thermo Fisher Scientific, Jumpcode Genomics, More Nov 18, 2022 In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More Nov 17, 2022 Biomarker Predicts Immunotherapy Benefit in Head and Neck Cancer but Commercial Path Unclear Premium Nov 2, 2022 Caris Life Sciences Adds Everything Genetic as UK Distributor Oct 28, 2022 In Brief This Week: OpGen, MDxHealth, Dante Genomics, More Oct 14, 2022 People in the News at Caris Life Sciences, Quest Diagnostics, LetsGetChecked Oct 14, 2022 In Brief This Week: Thermo Fisher Scientific, Enzo Biochem, Codex DNA, More Sep 30, 2022 In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Sep 23, 2022 Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform Sep 16, 2022 People in the News at ARPA-H, Caris Life Sciences, Fabric Genomics, More Sep 15, 2022 BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Sep 2, 2022 In Brief This Week: Illumina, Interpace, Genetic Signatures, Guardant Health, More Aug 12, 2022 In Brief This Week: Health Gene Technologies, IndyGeneUS AI, Natera, Proteintech Group, Bruker, More Aug 2, 2022 Caris, Xencor Ink Antibody Target Discovery Collaboration, License Agreement Jul 22, 2022 In Brief This Week: LumiraDx, Natera, Caris Life Sciences Jul 7, 2022 Caris Life Sciences Expands Partnership With Epic to Improve Molecular Testing Access Jul 1, 2022 In Brief This Week: Pacific Biosciences, Invitae, Grail, Mainz Biomed, Molzym, More Jun 2, 2022 Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership May 6, 2022 In Brief This Week: Sema4, Mirvie, Caris Life Sciences, Prenetics, 23andMe, More Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.